Pages that link to "Q38356199"

The following pages link to Assembly and release of SIV env proteins with full-length or truncated cytoplasmic domains (Q38356199):

Displaying 21 items.

• Prevention of poxvirus infection by tetrapyrroles (Q24806638) (← links)
• Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity. (Q33639849) (← links)
• Intracellular interaction of simian immunodeficiency virus Gag and Env proteins (Q33819271) (← links)
• Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals (Q33843329) (← links)
• Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization (Q33873610) (← links)
• Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines (Q33916676) (← links)
• Budding of enveloped viruses from the plasma membrane. (Q34065642) (← links)
• Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus (Q34364045) (← links)
• Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus (Q34744920) (← links)
• Fusogenic variants of a noncytopathic paramyxovirus. (Q35785263) (← links)
• Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes (Q35877383) (← links)
• Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection (Q36459268) (← links)
• Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B. (Q36464264) (← links)
• Virus-like particles: designing an effective AIDS vaccine (Q36602273) (← links)
• Identification of two intracellular mechanisms leading to reduced expression of oncoretrovirus envelope glycoproteins at the cell surface (Q39593725) (← links)
• Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus (Q39700279) (← links)
• Foamy virus envelope glycoprotein is sufficient for particle budding and release (Q39700302) (← links)
• Membrane-proximal cytoplasmic domain of Moloney murine leukemia virus envelope tail facilitates fusion (Q40020345) (← links)
• Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity. (Q40468605) (← links)
• Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines (Q40835166) (← links)
• Truncating the Gp41 Cytoplasmic Tail of SIV Decreases Sensitivity to Neutralizing Antibodies without Increasing Envelope Content of Virions (Q47398548) (← links)